Article
Stroke rates, risk factors, and aspirin prescribing trends in the Canadian Fabry Disease Initiative cohort
2024-07-17
Abstract excerpt
<h4>Background</h4> Fabry disease (FD) is an X-linked disorder caused by deleterious variants in GLA. Cardiovascular disease (CVD) causes premature mortality in FD. Hope for aspirin (acetylsalicylic acid, ASA) to reduce CVD risks in FD as primary prevention may have been tempered by the 2018 ARRIVE, ASCEND, and ASPREE clinical trials. It is unclear how new ASA guidance applies to FD patients, who have a high rate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 572646da-e7bf-538d-a595-75cf5e919037
- DOI
- 10.1101/2024.07.17.24310571
